Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
bazedoxifene estrogen receptor NA Successful target TTD , DGIDB Uterus[MeSHID:D014599]
Disease[MeSHID:D004194]
Osteoporosis
Postmenopausal[MeSHID:D015663]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Osteopetrosis[MeSHID:D010022]		 0.32 approved antagonist
bazedoxifene estrogen receptor NA Successful target TTD , DGIDB Uterus[MeSHID:D014599]
Disease[MeSHID:D004194]
Osteoporosis
Postmenopausal[MeSHID:D015663]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Osteopetrosis[MeSHID:D010022]		 0.32 approved unknown
bazedoxifene estrogen receptor alpha small molecule NA drugbank , DGIDB Uterus[MeSHID:D014599]
Disease[MeSHID:D004194]
Osteoporosis
Postmenopausal[MeSHID:D015663]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Osteopetrosis[MeSHID:D010022]		 0.32 approved,investigational antagonist,agonist
bazedoxifene estrogen receptor beta small molecule NA drugbank , DGIDB Uterus[MeSHID:D014599]
Disease[MeSHID:D004194]
Osteoporosis
Postmenopausal[MeSHID:D015663]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Osteopetrosis[MeSHID:D010022]		 0.69 approved,investigational unknown
bazedoxifene estrogen receptor beta small molecule NA drugbank , DGIDB Uterus[MeSHID:D014599]
Disease[MeSHID:D004194]
Osteoporosis
Postmenopausal[MeSHID:D015663]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Osteopetrosis[MeSHID:D010022]		 0.69 approved,investigational antagonist
click here to return to the previous page